Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy.
Saved in:
| Title: | Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy. |
|---|---|
| Authors: | Cook DP; Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Wu AY; Department of Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Thomas CM; Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Hamilton RG; Department of Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Peebles RS Jr; Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Tennessee Valley Healthcare System, United States Department of Veterans Affairs, Nashville, Tennessee, USA., Kerchberger VE; Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. |
| Source: | Allergy [Allergy] 2024 Dec; Vol. 79 (12), pp. 3528-3533. Date of Electronic Publication: 2024 Jun 16. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1398-9995 (Electronic) Linking ISSN: 01054538 NLM ISO Abbreviation: Allergy Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1398-9995 |
|---|---|
| DOI: | 10.1111/all.16198 |
